Home/Filings/4/0001628280-24-041739
4//SEC Filing

Rosenbaum David P. 4

Accession 0001628280-24-041739

CIK 0001437402other

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 4:34 PM ET

Size

6.5 KB

Accession

0001628280-24-041739

Insider Transaction Report

Form 4
Period: 2024-09-27
Rosenbaum David P.
SVP, Drug Development
Transactions
  • Sale

    Common Stock

    2024-09-27$6.92/sh49,564$342,983301,946 total
Holdings
  • Common Stock

    (indirect: By Trust)
    77,592
  • Common Stock

    (indirect: By Spouse)
    153,616
Footnotes (3)
  • [F1]Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 17, 2024.
  • [F2]The shares are directly held by the Reporting Person's wife.
  • [F3]The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.

Issuer

ARDELYX, INC.

CIK 0001437402

Entity typeother

Related Parties

1
  • filerCIK 0001611311

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:34 PM ET
Size
6.5 KB